Zéphir H, Fajardy I, Outteryck O, Blanc F, Roger N, Fleury M, Rudolf G, Marignier R, Vukusic S, Confavreux C, Vermersch P, de Seze J
Pôle Neurologique, Hôpital Roger Salengro, CHRU de Lille, 59037 Lille, France.
Mult Scler. 2009 May;15(5):571-9. doi: 10.1177/1352458508102085. Epub 2009 Mar 19.
To establish whether or not multiple sclerosis (MS) and neuromyelitis optica (NMO) are different pathological entities, we wondered whether MS patients and NMO patients share the same pattern of human leukocyte antigen (HLA) predisposition.
To study a putative association between susceptibility to NMO and HLA class I or class II loci in Caucasians.
A total of 39 unrelated Caucasian patients with NMO and six patients at a high risk of converting to NMO were studied. DNA genotyping of HLA class I and class II loci was assessed and allelic frequencies were reported at a high-resolution level. A case-control study by comparing the allelic distribution in the NMO patients with that of a French Caucasian MS group and a French Caucasian healthy group was carried out.
The frequencies of HLA-DQA1, DQB1, and HLA-DRB1 DR2 alleles in the NMO group were intermediate between the healthy control group and the MS group. The DPB1*0501 allele was not increased in the NMO group compared with the healthy control group. The distribution of HLA-DRB1 allele enabled to distinguish between NMO-IgG-positive patients and healthy controls (P = 0.01). NMO-IgG-negative patients presented an HLA II pattern closer to that of the MS group (P = 0.01).
In contrast to the reported results in Asian opticospinal MS, we found no association between the DPB1*0501 allele and NMO in our Caucasian patients. Moreover, we suggest that NMO-IgG-positive patients could represent a distinct NMO group in terms of their genetic susceptibility.
为确定多发性硬化症(MS)和视神经脊髓炎(NMO)是否为不同的病理实体,我们想知道MS患者和NMO患者是否具有相同的人类白细胞抗原(HLA)易感性模式。
研究高加索人群中NMO易感性与HLA I类或II类基因座之间的假定关联。
共研究了39例无亲缘关系的高加索NMO患者和6例转化为NMO风险较高的患者。对HLA I类和II类基因座进行DNA基因分型评估,并在高分辨率水平报告等位基因频率。通过比较NMO患者与法国高加索MS组和法国高加索健康组的等位基因分布进行病例对照研究。
NMO组中HLA-DQA1、DQB1和HLA-DRB1 DR2等位基因的频率介于健康对照组和MS组之间。与健康对照组相比,NMO组中DPB1*0501等位基因没有增加。HLA-DRB1等位基因的分布能够区分NMO-IgG阳性患者和健康对照组(P = 0.01)。NMO-IgG阴性患者的HLA II模式更接近MS组(P = 0.01)。
与亚洲视神经脊髓型MS的报道结果相反,我们在高加索患者中未发现DPB1*0501等位基因与NMO之间的关联。此外,我们认为NMO-IgG阳性患者在遗传易感性方面可能代表一个独特的NMO组。